O'Dell Group, LLC Abb Vie Inc. Transaction History

O'Dell Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$137.6 - $154.97 $104,988 - $118,242	763 New	763 $118,000
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $25,441 - $31,660	192 New	192 $25,000
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $13,421 - $15,393	100 Added 108.7%	192 $26,000
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $9,788 - $11,111	92 New	92 $10,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of O'Dell Group, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Dell Group, LLC with notifications on news.